Popular Articles

Anaesthetists Receive New Guidance On Managing Potentially Fatal Anaphylactic Reactions During Surgery
Anaesthetists in the UK and Ireland have been issued with new guidelines on how to

Radiotherapy Link To Breast Cancer And Heart Disease Found
Scientists have found a way to identify breast cancer patients at risk of heart disease after radiotherapy, according to a report published yesterday.
News of the day
Blogs Comment On Tiller's Death, Sotomayor, Other Topics
The following summarizes selected women"s health-related blog entries.~ "Dr. Tiller -- A Gynecological Superhero," Frances Irwin, Below the Waist: Kansas abortion provider George Tiller, who was shot to death on Sunday, was "a superhero" who "never failed to serve his patients regardless of the level of property damage, physical injury and intimidation he was subjected to as a result of his service," Irwin, who works for a Wisconsin-based family planning agency, writes. Irwin notes that, for nearly a year, the clinic she works at has been targeted by "pro-life" demonstrators. At various points they"ve carried signs reading, "Family planners promote child promiscuity," "Stop ALL Abortion," "Birth Control Leads to Abortion," and that new signs mention her by name. In the wake of Tiller"s death, Irwin writes that she "realize[s] that I could be intentionally injured by someone who opposes my work." She concludes, "To some extent allowing myself to worry about this feels like cowardice because Dr. Tiller was a superhero. And that"s a lot to aspire to" (Irwin, Below the Waist, 6/4).~ "Let"s Make an Abortion Deal," William Saletan, Slate"s "Human Nature": Some participants in the White House meetings to discuss abortion in the U.S. "aren"t trying hard enough" to find "common ground" and are "refusing the simplest concessions," Saletan writes. Saletan offers four recommendations to advocates on both side of the debate, including removing the distinction between reducing the number of abortions versus reducing the need for abortions. He writes, "No ordinary person sees a difference" between the two,"[s]o let"s focus on reduction through voluntary means and stop quibbling over how it"s described." His other recommendations include antiabortion-rights advocates conceding to increased access to contraception and both sides giving up "extremism." Saletan"s final recommendation is that abortion-rights opponents allow federal funding for reproductive health groups that offer abortion information or services. He writes that a ban on direct funding for abortions is "fine, " but the "indirect funding Obama restored is hardly radical," adding, "You might even discover that the most efficient way to prevent abortions in the long term is to fund the family planning organizations you keep trying to defund" (Saletan, "Human Nature," Slate, 6/4).~ "The ABCs of Antiabortion Activism," Tracy Clark-Flory, Salon"s "Broadsheet": Tiller"s murder "has opened up a Pandora"s box for pro-lifers, giving rise to all sorts of troublesome questions about the culpability of lenient law enforcement and the movement itself," Clark-Flory writes. She continues, "They certainly won"t find salvation from Pandagon"s Amanda Marcotte, who got her mitts on a disturbing antiabortion activist handbook" now online from Justice for All "that lays bare some of the lies, deception and cynical manipulation that might have led to Tiller"s assassination." According to Clark-Flory, "The single justifiable situation for an abortion is ectopic pregnancy, the manual explains," adding, "Deception of that sort is found throughout the handbook." She writes, "Activists are instructed that when confronting targets they are to pretend that they"re A-OK with contraception" so that "their mark will let his or her guard down and think that, you know, there"s actually a rational, fact-based discussion to be had." Clark-Flory continues, "The truth, of course, is that the manual goes on to arm activists with medical misinformation that they can spread about birth control." She concludes that Marcotte "puts this tactical deceit in perfect context: "It shows one face to the initiated and another to the public, especially on the topic of contraception. Once you realize this, the movement"s half-hearted denunciations of Dr. Tiller"s murder, coupled with the enthusiastic return to calling Dr. Tiller a monster, become all the more chilling"" (Clark-Flory, "Broadsheet," Salon, 6/4).~ "Late-Term Abortions: Facts
Health Insurance

Research-based Pharmaceutical Industry's Health Contribution Presented To Special United Nations Session On Health In Africa And Other Countries

The IFPMA was invited to attend a special session of the United Nations (UN) in Geneva on health in Africa and other least developed countries, organized by the UN Economic and Social Commission (ECOSOC). Michael D. Boyd, Acting Director General of the IFPMA, gave a briefing on the research-based pharmaceutical industry"s contribution to improving health in the developing world, speaking to an audience which included foreign ministers of UN Member States and senior UN officials. Mr. Boyd commented: "A quiet transformation has been going on over the last decade or so, strengthening links between the developed world and least developed countries, especially in the area of health. As a single industry sector, the IFPMA"s member companies have made an unprecedented contribution to improving health in the countries which have the greatest needs." Since the inception of the UN Millennium Development Goals, through to the end of 2007, IFPMA member companies made available enough medical assistance to reach nearly 2 billion people in low and middle income countries - assistance conservatively valued at USD 9.2 billion(1). The growing range of industry-backed partnership programs to help improve health in developing countries is documented in an annual IFPMA partnerships book(2) and in a searchable online database, at http://www.ifpma.org/healthpartnerships. The research-based pharmaceutical industry has also been steadily increasing its R&D into diseases of the developing world. In 2005, IFPMA Member Companies were working on 32 new medicine projects for the top 10 diseases of the developing world; this year, they are working on 75 such projects(3) . The research-based pharmaceutical industry"s commitment to help develop new medicines for the developing world is underlined by the existence of five company R&D centers which are dedicated purely to research into diseases which disproportionately affect developing countries(4). (1) See here. (2) Partnerships to Build Healthier Societies in the Developing World - May 2009. See here. (3) See here. (4) Industry Dedicated DDW R&D Centers: - AstraZeneca, Bangalore Research Institute, India (Tuberculosis) - GlaxoSmithKline, DDW Drug Discovery Center, Tres Cantos, Spain (Malaria, Tuberculosis, Kinetoplastids) - Lilly (+ Merck & Co., Inc.), Lilly TB Drug Discovery Initiative, Seattle, USA, (Tuberculosis) - Novartis, Novartis Institute for Tropical Diseases, Singapore (Dengue Fever, Malaria, Tuberculosis) - Novartis, Novartis Vaccines Institute for Global Health, Siena, Italy (Diarrheal diseases, Salmonella). IFPMA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):